Tocilizumab for the Treatment of SLC29A3 Mutation Positive PHID Syndrome

Rafiq, NK; Hussain, K; Brogan, PA; (2017) Tocilizumab for the Treatment of SLC29A3 Mutation Positive PHID Syndrome. Pediatrics , 140 (5) , Article e20163148. 10.1542/peds.2016-3148 .

https://ift.tt/2IcudGZ